Orion's Financial Objectives
- Growing net sales more rapidly than growth of the pharmaceuticals market.
- Maintaining profitability at a good level, the aim being operating profit that exceeds 22% of net sales.
- Keeping the equity ratio at least 50%.
- Distributing an annual dividend that in the next few years will be at least EUR 1.30 per share, and increasing the dividend in the long term.
Operating profit in 2016 included EUR 22 million of capital gains.